Everotas 0.25mg Tablet
Manufacturer
Intas Pharmaceuticals Ltd
Salt Composition
Everolimus (0.25mg)
Key Information
Short Description
Everotas 0.25mg Tablet is used for the prevention of organ rejection in transplant patients and in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.
Dosage Form
Tablet
Introduction
Everotas 0.25mg Tablet is used for the prevention of organ rejection in transplant patients. It regulates the body's immune response, so the body can accept the new organ. It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Everotas 0.25mg Tablet may be taken with or without food but it is better to take it at a fixed time.
How it works
Everotas 0.25mg Tablet suppresses the activity of body's immune system and prevents rejection of the transplanted organ.
Quick Tips
Everotas 0.25mg Tablet is given for the treatment of certain cancers and to prevent organ transplant rejection. It may affect male or female fertility; consult your doctor if you are planning to have a child. Inform your doctor straight away if you think you are getting a sore throat or if you have a high temperature. While you are taking Everotas 0.25mg Tablet do not take any vaccinations without talking to your doctor first. If you are having an operation or dental treatment, always tell the person carrying out the treatment that you are taking Everotas 0.25mg Tablet. Do not drink grapefruit juice while you are taking this medicine.